BioAmber (BIOA) Tops Q1 EPS by 2c

BioAmber (NYSE: BIOA) reported Q1 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.37 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• CrowdStrike Holdings Inc. (CRWD) Tops Q1 EPS by 3c, Offers Guidance
• Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply